>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
TNFR2激活NF-κB信号通路调控线粒体融合蛋白OPA1在心力衰竭中的作用
作者:徐海燕1  刘海浪1  张媛媛2  胡婷婷1  林振宇1  杨静1 
单位:1. 南京医科大学附属淮安第一医院心内科, 江苏 淮安 223000;
2. 南京医科大学附属淮安第一医院检验科, 江苏 淮安 223000
关键词:心力衰竭 肿瘤坏死因子受体-2 线粒体动力学 核转录因子-κB 视神经萎缩蛋白1 
分类号:R541.6
出版年·卷·期(页码):2020·39·第一期(17-22)
摘要:

目的:探讨肿瘤坏死因子受体(TNFR)2通过调节视神经萎缩蛋白1(OPA1)促进线粒体融合在慢性心力衰竭中可能的保护机制。方法:构建SiRNA靶向沉默TNFR1(TNFR1-KD)的心肌细胞H9c2。肿瘤坏死因子-α(TNF-α)(0.5 ng·ml-1)刺激TNFR1-KD心肌细胞H9c2和靶向沉默OPA1的TNFR1-KD心肌细胞H9c2,电镜下测定线粒体形态和数量,荧光素酶-荧光素法测定ATP酶活性。蛋白质印迹法测定PGC1α、OPA1、Mfn1、Mfn2、Drp1的蛋白表达水平;ELISA检测转移到细胞核内的p65蛋白、IL-1β和IL-6含量。结果:TNFR1-KD心肌细胞H9c2的TNFR1表达量在转染48 h最低。在TNFR1-KD心肌细胞H9c2,与安慰剂组比较,TNF-α刺激组的线粒体数量下降24%,平均线粒体面积增加28%,ATP酶活性增加35%,差异均具有统计学意义(均P<0.05)。TNF-α刺激组的OPA1蛋白表达水平明显升高,差异具有统计学意义(P<0.05)。靶向沉默OPA1的TNFR1-KD心肌细胞H9c2组(OPA1-siRNA组)较空白对照组(NC-siRNA组)中的线粒体数量增加40%,平均线粒体面积下降32%,ATP酶活性下降25%,差异均具有统计学意义(均P<0.05)。在TNFR1-KD心肌细胞H9c2中,PDTC可显著抑制核转录因子κB(NF-κB)通路活化,细胞核内的NF-κB p65蛋白含量降低,IL-1β、IL-6表达下降,线粒体OPA1蛋白含量下降。结论:TNFR2激活NF-κB信号通路调控OPA1促进线粒体融合。

Objective: To study how tumor necrosis factor receptor(TNFR)2 activation mediates the effects of optic atrophy1(OPA1) on mitochondria fusion. Methods: Rat myocardial cell line H9c2 treated with siRNA targeting TNFR1(TNFR1-KD) were used to study the effects of TNFR2 activation on mitochondrial function. H9c2 cells with TNFR1-KD and TNFR1-KD cells transfected with OPA1-siRNA were treated with tumor necrosis factor α (TNFα,0.5 ng·ml-1). The electron microscopic examination was done to analyze the mitochondrial morphology number of mitochondria. The intracellular ATP activity was detected by firefly luciferase reaction. Western blot was used to examine the expression of PGC1α, OPA1, Mfn1, Mfn2 and Drp1 and ELISA was used to examine the expression of p65, IL-1β and IL-6. Results: The expression of TNFR1 in TNFR1-KD H9c2 cells was the lowest at 48 h after transfection. Compared with placebo-treated cells, TNFR1-KD H9c2 cells of TNF-α treatment group exhibited increases in mitochondrial fusion, a change that was associated with a 24% decrease in mitochondrial number, a 28% increase in mitochondrial area and a 35% increase in intracellular ATP levels (all P<0.05). The expression of OPA1 protein was significantly increased in TNF-α group. TNFR1-KD H9c2 cells transfected with OPA1-siRNA exhibited a 40% increase in mitochondrial number, a 32% decrease in mitochondrial area, and a 25% decrease in intracellular ATP levels compared with untransfected cells after TNFR2 stimulation (all P<0.05). The levels of p65 protein in the nucleus, IL-1β, IL-6 and OPA1 were significantly lower in TNFR1-KD H9c2 cells of PDTC treatment group than placebo-treated group. Conclusion: TNFR2 activation promotes mitochondrial fusion by upregulating OPA1 expression via NF-κB signaling pathway.

参考文献:

[1] DIWAN A,DIBBS Z,NEMOTO S,et al.Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes[J].Circulation,2004,109(2):262-268.
[2] BOZKURT B,KRIBBS S B,CLUBB F J Jr,et al.Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats[J].Circulation,1998,97(14):1382-1391.
[3] LI Y Y,FENG Y Q,KADOKAMI T,et al.Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosisfactor alpha canbe modulated by anti-tumor necrosis factor alpha therapy[J].Proc Natl Acad Sci U S A,2000,97(23):12746-12751.
[4] COLETTA A P,CLARK A L,BANARJEE P,et al.Clinical trials update:RENEWAL (RENAISSANCE and RECOVER) and ATTACH[J].Eur J Heart Fail,2002,4:559-561.
[5] CHUNG E S,PACKER M,LO K H,et al.Anti-TNF Therapy Against Congestive Heart Failure Investigators.Randomized,double-blind,placebo-controlled,pilot trial of infliximab,a chimeric monoclonal antibody to tumor necrosis factor-alpha,in patients with moderate-to-severe heart failure:results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial[J].Circulation,2003,107:3133-3140.
[6] VANDENABEELE P,DECLERCQ W,BEYAERT R,et al.Two tumour necrosis factor receptors:structure and function[J].Trends Cell Biol,1995,5(10):392-399.
[7] MARTI C N,KHAN H,MANN D L,et al.Soluble tumor necrosis factor receptors and heart failure risk in older adults:Health,Aging,and Body Composition (Health ABC) Study[J].Circ Heart Fail,2014,7(1):5-11.
[8] GARLIE J B,HAMID T,GU Y,et al.Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo[J].Basic Res Cardiol,2011,106(6):1193-1205.
[9] MVLLER-RISCHART A K,PILSLl A,BEAUDETTE P,et al.The E3 ligase parkin maintains mitochondrial integrity by in- creasing linear ubiquitination of NEMO[J].Mol Cell,2013,49(5):908-921.
[10] DRABAREK B,DYMKOWSKA D,SZCZEPANOWSKA J,et al.TNFα affects energy metabolism and stimulates biogenesis of mitochondria in EA.hy926 endothelial cells[J].Int J Biochem Cell Biol,2012,44(9):1390-1397.
[11] ZHANG Y,ZHANG J,BUTLER J,et al.Contemporary epidemiology,management,and outcomes of patients hospitalized for heart failure in China:results from the China heart failure (China-HF) registry[J].J Card Fail,2017,23(12):868-875.
[12] YANCY C W,JESSUP M,BOZKURT B,et al.2017 ACC / AHA / HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J].Circulation,2017,136(6):e137-161.
[13] MARÍN-GARCÍA,AKHMEDOV A T.Mitochondrial dynamics and cell death in heart failure[J].Heart Fail Rev,2016,21(2):123-136.
[14] CHEN L,GONG Q,STICE J P,et al.Mitochondrial OPA1,apoptosis,and heart failure[J].Cardiovasc Res,2009,84(1):91-99.
[15] FREZZA C,CIPOLAT S,MARTINS DE BRITO O,et al.OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion[J].Cell,2006,126(1):177-189.
[16] LAFORGE M,RODRIGUES V,SILVESTRE R,et al.NF-κBpathway controls mitochondrial dynamics[J].Cell Death Differ,2016,23(1):89-98.
[17] HAN A,LU Y,ZHENG Q,et al.Qiliqiangxin attenuates cardiac remodeling via inhibition of TGF-β1/Smad3 and NF-κB signaling pathways in a rat model of myocardial infarction[J].Cell Physiol Biochem,2018,45(5):1797-1806.
[18] JIN J L,LV R G,GUO J,et al.Improvement of left ventricular remodelling by inhibition of NF-κB in a rat model of myocardial infarction[J].Heart Lung Circ,2016,25(10):1007-1101.
[19] BROWN D A,PERRY J B,ALLEN M E,et al.Expert consensus document:Mitochondrial function as a therapeutic target in heart failure[J].Nat Rev Cardiol,2017,14(4):238-250.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 237988 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364